Neuroendocrine mechanisms by which selective Leydig cell castration unleashes increased pulsatile LH release

Am J Physiol. 1997 Feb;272(2 Pt 2):R464-74. doi: 10.1152/ajpregu.1997.272.2.R464.

Abstract

A novel pharmacological model of acute reversible Leydig cell "castration" induced by a steroidogenic enzyme inhibitor, ketoconazole, achieves marked hypoandrogenemia in healthy men with an attendant 2.5-fold increase in 24-h mean serum luteinizing hormone (LH) concentrations. Mechanistically, the unleashing of amplified pulsatile LH release can be accounted for by any of three distinct models of deconvolution-estimated gonadotropin secretion, all of which are marked by a nearly twofold acceleration in LH secretory burst frequency. In addition, the models variously also predict concomitant prolongation of the endogenous LH half-life, an augmented LH secretory burst mass and duration, and/or the emergence of significant basal LH secretion. The nyctohemeral (cosinor analysis) rhythmicity of serum LH concentrations is not disturbed when androgenic negative-feedback signaling is withdrawn abruptly, but the apparent process randomness of LH release increases, as quantified by higher approximate entropy values. Thus we conclude that an intact (closed loop) androgen-mediated negative-feedback network in the adult human male is required to sustain low-frequency pulsatile LH release in a quantifiably orderly manner.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Androgens / deficiency
  • Entropy
  • Half-Life
  • Humans
  • Ketoconazole / pharmacology
  • Leydig Cells / drug effects
  • Leydig Cells / physiology*
  • Luteinizing Hormone / blood*
  • Male
  • Neurosecretory Systems / physiology*
  • Orchiectomy*
  • Pulsatile Flow

Substances

  • Androgens
  • Luteinizing Hormone
  • Ketoconazole